Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | SCN9A | Q15858 | 8/20 | 0.40 |
| ▸ | POLB | P06746 | 2/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | CA12 | O43570 | 1/20 | 0.36 |
| ▸ | CA6 | P23280 | 1/20 | 0.36 |
| ▸ | CA7 | P43166 | 1/20 | 0.36 |
| ▸ | RECQL | P46063 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL261011 | 0.98 | ACE2 (0.46) | ACE2ALDH1A1KDM4ELMNAKMT2A | |
| SCHEMBL20655943 | 0.98 | ACE2 (0.46) | ACE2ALDH1A1KDM4ELMNAKMT2A | |
| SCHEMBL22030391 | 0.92 | ALDH1A1 (0.41) | ACE2ALDH1A1KDM4ELMNAKMT2A | |
| SCHEMBL471729 | 0.91 | ALDH1A1 (0.50) | ALDH1A1KDM4ELMNAKMT2ARAB9A | |
| SCHEMBL8371323 | 0.89 | ALDH1A1 (0.40) | ACE2ALDH1A1KDM4ELMNAKMT2A | |
| SCHEMBL22030392 | 0.89 | ALDH1A1 (0.49) | ALDH1A1KDM4ELMNAKMT2ARAB9A | |
| SCHEMBL22030393 | 0.87 | ALDH1A1 (0.42) | ACE2ALDH1A1KDM4ELMNAKMT2A | |
| SCHEMBL21790316 | 0.84 | ALDH1A1 (0.39) | ACE2ALDH1A1KDM4ELMNAKMT2A | |
| SCHEMBL6289546 | 0.83 | KMT2A (0.46) | ALDH1A1KDM4ELMNAKMT2ARAB9A | |
| SCHEMBL20734660 | 0.82 | KMT2A (0.48) | ALDH1A1KDM4ELMNAKMT2ARAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 506 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120041182-A | Particle size-controllable epoxy resin fracturing propping agent and preparation method thereof | 江苏扬农化工集团有限公司 | 2025-05-27 | — | — | CN | claimed |
| CN-119752183-A | Preparation method of epoxy resin fracturing propping agent with high heat resistance and low breakage rate | 江苏扬农化工集团有限公司 | 2025-04-04 | — | — | CN | claimed |
| EP-2989170-B1 | MULTILAYER STRUCTURE COMPRISING A LAYER OF SUPRAMOLECULAR MATERIAL AND METHOD FOR THE PRODUCTION THEREOF | ARKEMA FRANCE (FR) | 2019-05-22 | — | — | EP | claimed |
| CN-105143374-B | Multilayer structure making and its manufacturing method including supramolecular materials layer | 阿科玛法国公司 | 2018-12-11 | — | — | CN | claimed |
| EP-2457940-B1 | Fluorinated supramolecular polymers | SUPRAPOLIX BV (NL) | 2018-10-24 | — | — | EP | claimed |
| US-10093767-B2 | Multilayer structure comprising a layer of supramolecular material and method for the production thereof | ARKEMA FRANCE (FR) | 2018-10-09 | — | — | US | claimed |
| EP-2438114-B1 | USE OF MOLECULES HAVING ASSOCIATIVE GROUPS AS HARDENERS FOR THERMOSETTING RESINS | ARKEMA FRANCE (FR) | 2017-11-08 | — | — | EP | claimed |
| EP-2217641-B1 | MATERIAL FORMED FROM DENDRITIC MOLECULES CONTAINING ASSOCIATIVE GROUPS | ARKEMA FRANCE (FR) | 2017-03-08 | — | — | EP | claimed |
| EP-2414427-B1 | USE, AS A SHOCK ABSORBER, OF A MATERIAL FORMED FROM BRANCHED MOLECULES CONTAINING ASSOCIATIVE GROUPS | ARKEMA FRANCE (FR) | 2017-03-01 | — | — | EP | claimed |
| EP-2331641-B1 | NEUTRALIZING AGENT FOR PAINTS | ARKEMA FRANCE (FR) | 2016-12-21 | — | — | EP | claimed |
| EP-2235070-A1 | POLYMERIC ADDITIVES OBTAINED BY SALIFICATION OF COPOLYMERS | ARKEMA FRANCE (FR) | 2010-10-06 | — | — | EP | claimed |
| EP-2225312-A2 | METHOD OF PREPARING A MATERIAL FORMED FROM BRANCHED MOLECULES COMPRISING ASSOCIATIVE GROUPS | ARKEMA FRANCE (FR) | 2010-09-08 | — | — | EP | claimed |
| EP-2217641-A1 | MATERIAL FORMED FROM DENDRITIC MOLECULES CONTAINING ASSOCIATIVE GROUPS | ARKEMA FRANCE (FR) | 2010-08-18 | — | — | EP | claimed |
| US-20100135940-A1 | SEMI-CRYSTALLINE SUPRAMOLECULAR POLYMERS | ARKEMA FRANCE (FR) | 2010-06-03 | — | — | US | claimed |
| US-20100120983-A1 | STYRENE/ANHYDRIDE POLYMERIC MATERIAL AND GRAFT HAVING ENHANCED PROPERTIES | ARKEMA FRANCE (FR) | 2010-05-13 | — | — | US | claimed |
| WO-2010037953-A1 | NEUTRALIZING AGENT FOR PAINTS | ARKEMA FRANCE (FR) | 2010-04-08 | — | — | WO | claimed |
| WO-2009141558-A2 | METHOD FOR SYNTHESIZING SUPRAMOLECULAR MATERIALS | ARKEMA FRANCE (FR) | 2009-11-26 | — | — | WO | claimed |
| WO-2009080499-A1 | POLYMERIC ADDITIVES OBTAINED BY SALIFICATION OF COPOLYMERS | ARKEMA FRANCE (FR) | 2009-07-02 | — | — | WO | claimed |
| WO-2009081065-A2 | METHOD OF PREPARING A MATERIAL FORMED FROM BRANCHED MOLECULES COMPRISING ASSOCIATIVE GROUPS | ARKEMA FRANCE (FR) | 2009-07-02 | — | — | WO | claimed |
| WO-2009071554-A1 | MATERIAL FORMED FROM DENDRITIC MOLECULES CONTAINING ASSOCIATIVE GROUPS | ARKEMA FRANCE (FR) | 2009-06-11 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100135940-A1 | SEMI-CRYSTALLINE SUPRAMOLECULAR POLYMERS | FASN, FFAR3, FFAR2 | ACE2 2423/4885ALDH1A1 4487/4885KDM4E 3539/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.